Bone Marrow Pathology in Cold Agglutinin‐Mediated Autoimmune Hemolytic Anemia: A Study of 56 Cases
European Journal of Haematology · 2026-08 · 117 (2) · 384-395
DOI: 10.1111/ejh.70194 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Haematology, online erschienen am 17.04.2026. Verfasst von Anne-Marie L Becking und 6 weiteren Autor:innen. Beteiligte Einrichtung: Amsterdam University Medical Centers, Department of Hematology, University of Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands. Hauptthemen laut MEDLINE: Anemia, Hemolytic, Autoimmune, Bone Marrow. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Cold agglutinin disease (CAD) is a rare form of autoimmune hemolytic anemia (AIHA). CAD occurs in the context of a small clonal B‐cell lymphoproliferation restricted to blood and/or bone marrow (BM), without overt or extramedullary lymphoma. The WHO‐HAEM5 introduced a description of the CAD‐associated lymphoproliferative disorder (CAD‐LPD) in the BM as a desirable criterium for CAD. Still, data on BM pathology underlying CAD remain scarce. We assessed the clinical and pathologic characteristics of a large patient cohort with cold‐type AIHA. A total of 85 BM biopsies of 56 patients were evaluated. In 10 patients (18%), pathology revision revealed other overt B‐cell malignancies leading to a diagnosis of cold agglutinin syndrome. In the remaining 46, evidence for B‐cell clonality was found in the vast majority (45; 98%), manifesting as a paraproteinemia and/or clonal B‐cells or plasma cells in BM. Most of these 45 had an M‐protein (89%), evidence of monoclonal B‐cells and/or plasma cells in BM tissue (89%), and were MYD88 wild‐type (100%). Surprisingly, while ancillary methods detected clonality in the majority (84%), only 5 (11%) of 45 CAD cases strictly fulfilled the WHO‐HAEM5 morphological description for CAD‐LPD. These data imply that sensitive techniques should be used in BM evaluation in CAD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Amsterdam University Medical Centers, Department of Hematology, University of Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands.
- Lymphoma and Myeloma Center Amsterdam (LYMMCARE), Amsterdam, the Netherlands.
- Sanquin Research and Landsteiner Laboratory of the Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands.
- Department of Hematology, Leiden University Medical Center, Leiden, the Netherlands.
- Amsterdam University Medical Centers, Department of Pathology, University of Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands.
ORCID-Profile: Anne-Marie L Becking, Femke V M Mulder, Josephine M I Vos
Zitieren
APA
Becking, A. L., Bernelot Moens, S. J., Kersten, M. J., Mulder, F. V. M., Pals, S. T., Koens, L., & Vos, J. M. I. (2026). Bone Marrow Pathology in Cold Agglutinin‐Mediated Autoimmune Hemolytic Anemia: A Study of 56 Cases. European Journal of Haematology, 117(2), 384-395. https://doi.org/10.1111/ejh.70194
Vancouver
Becking AL, Bernelot Moens SJ, Kersten MJ, Mulder FVM, Pals ST, Koens L, et al. Bone Marrow Pathology in Cold Agglutinin‐Mediated Autoimmune Hemolytic Anemia: A Study of 56 Cases. European Journal of Haematology. 2026;117(2):384-395. doi:10.1111/ejh.70194
BibTeX
@article{Becking2026,
author = {Becking, Anne-Marie L and Bernelot Moens, Sophie J and Kersten, Marie José and Mulder, Femke V M and Pals, Steven T and Koens, Lianne and Vos, Josephine M I},
title = {Bone Marrow Pathology in Cold Agglutinin‐Mediated Autoimmune Hemolytic Anemia: A Study of 56 Cases},
journal = {European Journal of Haematology},
year = {2026},
volume = {117},
number = {2},
pages = {384--395},
doi = {10.1111/ejh.70194}
}
EUVIMED